Scientific Symposium "FIGHTING VIRAL PERSISTENCE - LIV meets HOPE"

Hamburg April 12, 2024. At the scientific symposium "FIGHTING VIRAL PERSISTENCE - LIV meets HOPE", which took place at LIV today, LIV/UKE and HOPE scientists came together to present and discuss projects on various topics related to viral persistence.

The topics presented ranged from the characterization of the active HIV reservoir to innovative technologies in HIV cure research and advances in the study of associated herpesvirus infections and their impact.

"I would particularly like to thank the dedicated speakers for their high caliber presentations, which made a significant contribution to our shared understanding of viral persistence. The diverse perspectives and insights contributed to lively discussions and a fruitful exchange," said Ulrike Lange, head of the junior research group Genomics of Retroviral Infections at the LIV and organizer of the symposium on the LIV side.

The HIV Obstruction by Programmed Epigenetics (HOPE) Collaboratory is an international collaboratory funded by the National Institutes of Health (NIH) that focuses on HIV obstruction by programmed epigenetics in the context of developing an HIV cure. HOPE links 16 institutions worldwide and integrates findings from clinical trials that promise promising approaches to combat viral persistence.